Dr Reddy's launches generic cholesterol-lowering drug in US

Dr Reddy's Laboratories today launched generic version of Pfizer's Caduet tablets, a cholesterol-lowering drug, in the American market after getting the approval from the US health regulator.

The company has launched Amlodipine Besylate and Atorvastatin Calcium Tablets in the US market following the approval by the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a statement.

The company's product is the generic equivalent of Pfizer Inc's Caduet tablets, it added.

The Hyderabad-based firm's Amlodipine Besylate and Atorvastatin Calcium tablets are available in bottle counts of 30 and 90, the company said.

According to IMS Health sales data, Caduet tablets brand and generics had US sales of around USD 163 million for the most recent twelve months ending in January 2014.

Dr Reddy's Laboratories shares were trading at Rs 2,594 apiece on the BSE in afternoon trade, down 1.60 per cent from its previous close.


  • Banks have been reluctant to transmit RBI policy rate cuts to borrowers

    Banks have been slow in passing the benefit of repo rate cuts by the central bank to their borrowers.


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Arun Nigavekar

Ranking of higher education institutions

Given the massive popularity and growing influence of world university ...

Rajgopal Nidamboor

The pursuit of serene stillness

It may sound strange — that every change in the ...

Dharmendra Khandal

How positive intervention can go a long way

Ten years ago, Sariska tiger reserve declared that there were ...


William D. Green

Chairman & CEO, Accenture